Microvisk Technologies, the developer of the patented technology for point-of-care monitoring of blood coagulation for patients taking the drug warfarin, has raised £2 million by attracting three new investors and retaining support from its current private and institutional investors.
Based in Wales, Microvisk became an independent company in 2004 and is now developing the world’s first medical diagnostic strip based on a solid-state micro electro mechanical system, SmartStrip, and versatile hand-held reader. The money raised will take the research and development forward through 2010 for a launch of the SmartStrip system in 2011.
The Microvisk test is a completely solid-state system. The assessment of coagulation is measured by tiny multilayered paddles on the surface of the chip. In addition, the strip has an onboard memory to inform the test instrument of all manufacturing variables and the conditions under which the strip has been kept since manufacture.